ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3093 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3093; 2) Community: the network communities that were significantly associated with the response to NSC 3093; 3) Molecule: the relationships between components within communities and NSC 3093; 4) MDR: the compounds that were significantly associated with the NSC 3093.

NSC Compound Enrichment Correlation
NSC 683662 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[2-(dimethylamino)-1-oxoethoxy]-19-[(2-propenyl)amino]-, stereo 0.0100995289754787 0.36285587
NSC 690024 1,4-Butanediamine, N,N'-bis[3-[(phenylmethyl)amino]propyl]-,tetra(trifluoroacetate) 0.0100995289754787 0.37198497
NSC 692641 Null 0.0100995289754787 0.0513425
NSC 721075 Claritin 0.0100995289754787 0.026203604
NSC 746701 N-(4-Chlorophenyl)-N-({[2-(4-chlorophenyl)ethyl]amino]carbonothioyl)benzamide 0.0100995289754787 0.39344141
NSC 93287 Null 0.0100995289754787 0.473457
NSC 32937 Benzenamine, 4-(9-chloro-10-ethyl-9,10-dihydro-9-acridinyl)-N,N-dimethyl-, dihydrochloride 0.0102077332082016 0.54883797
NSC 333856 NSC 329083 0.0102077332082016 0.18104987
NSC 403376 Null 0.0102077332082016 0.035065069
NSC 58575 Pyrimidine, 2,4,5-trichloro-6-isopropyl- 0.0102077332082016 0.34593478
Total:65  Current:16    [First] [Prev] [Next] [Last]